06/05/2026
Trulieve Cannabis Corp. has announced approval to list its subordinate voting shares on the New York Stock Exchange, with trading expected to begin under the ticker TRLV on June 10, 2026.
The company says the move will make it the first U.S. cannabis operator to list on a major U.S. exchange. Until the NYSE listing takes effect, Trulieve expects its shares to continue trading on the Canadian Securities Exchange under TRUL and on the OTCQX under TCNNF until the close of market on June 9.
The listing follows a broader shift in the U.S. regulatory environment, including the reclassification of medical ma*****na to Schedule III and the creation of a DEA registration pathway for state-licensed medical ma*****na businesses. Trulieve also completed a restructuring that leaves its consolidated operations focused on state-licensed medical ma*****na activity.
Following that restructuring, the company reports 206 medical ma*****na dispensaries and 3.5 million square feet of DEA-registered production capacity.
Source: The Deep Dive